Biodegradable-polymer drug-eluting stents vs. bare metal stents vs. durable-polymer drug-eluting stents: a systematic review and Bayesian approach network meta-analysis
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Biodegradable-polymer drug-eluting stents vs. bare metal stents vs. durable-polymer drug-eluting stents: a systematic review and Bayesian approach network meta-analysis
Authors
Keywords
-
Journal
EUROPEAN HEART JOURNAL
Volume 35, Issue 17, Pages 1147-1158
Publisher
Oxford University Press (OUP)
Online
2014-01-24
DOI
10.1093/eurheartj/eht570
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Safety and efficacy of everolimus- versus sirolimus-eluting stents: A systematic review and meta-analysis of 11 randomized trials
- (2012) Kyung Woo Park et al. AMERICAN HEART JOURNAL
- Short- and Long-Term Outcomes With Drug-Eluting and Bare-Metal Coronary Stents
- (2012) Sripal Bangalore et al. CIRCULATION
- Everolimus-eluting versus sirolimus-eluting stents: an updated meta-analysis of randomized trials
- (2012) Antoinette de Waha et al. Clinical Research in Cardiology
- Effect of Biolimus-Eluting Stents With Biodegradable Polymer vs Bare-Metal Stents on Cardiovascular Events Among Patients With Acute Myocardial Infarction
- (2012) Lorenz Räber et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Primary Endpoint Results of the EVOLVE Trial
- (2012) Ian T. Meredith et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Stent thrombosis with drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis
- (2012) Tullio Palmerini et al. LANCET
- Everolimus-eluting stent versus bare-metal stent in ST-segment elevation myocardial infarction (EXAMINATION): 1 year results of a randomised controlled trial
- (2012) Manel Sabate et al. LANCET
- Stent Thrombogenicity Early in High-Risk Interventional Settings Is Driven by Stent Design and Deployment and Protected by Polymer-Drug Coatings
- (2011) Kumaran Kolandaivelu et al. CIRCULATION
- Drug-eluting versus bare-metal stents in saphenous vein graft lesions (ISAR-CABG): a randomised controlled superiority trial
- (2011) Julinda Mehilli et al. LANCET
- Long-term clinical outcomes of biodegradable polymer biolimus-eluting stents versus durable polymer sirolimus-eluting stents in patients with coronary artery disease (LEADERS): 4 year follow-up of a randomised non-inferiority trial
- (2011) Giulio G Stefanini et al. LANCET
- Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)
- (2010) et al. EUROPEAN HEART JOURNAL
- Clinical and Angiographic Outcomes After Treatment of De Novo Coronary Stenoses With a Novel Platinum Chromium Thin-Strut Stent
- (2010) Dean J. Kereiakes et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Second-generation everolimus-eluting and paclitaxel-eluting stents in real-life practice (COMPARE): a randomised trial
- (2010) Elvin Kedhi et al. LANCET
- Everolimus-Eluting versus Paclitaxel-Eluting Stents in Coronary Artery Disease
- (2010) Gregg W. Stone et al. NEW ENGLAND JOURNAL OF MEDICINE
- Drug-Eluting Versus Bare Metal Stents in Patients With ST-Segment–Elevation Myocardial Infarction
- (2008) Henning Kelbæk et al. CIRCULATION
- Delayed Arterial Healing and Increased Late Stent Thrombosis at Culprit Sites After Drug-Eluting Stent Placement for Acute Myocardial Infarction Patients
- (2008) Gaku Nakazawa et al. CIRCULATION
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started